期刊文献+

非酒精性脂肪肝病合并胰岛素抵抗患者血清chemerin和hs-CRP水平的研究 被引量:10

Study of serum chemerin and hs-CRP in patients with nonalcoholic fatty liver disease complicating insulin resistance
下载PDF
导出
摘要 目的测定非酒精性脂肪肝病(NAFLD)患者血清中视黄酸受体反应蛋白2(chemerin)、超敏C反应蛋白(hs-CRP)的表达水平,以及胰岛素抵抗指数(HOMA-IR),探讨chemerin在NAFLD发病中的机制。方法将NAFLD患者分为两组,NAFLD组(30例)和NAFLD+IR组(30例);并选择健康体检者30例作为健康对照组。用双抗体夹心酶联免疫吸附法检测血清chemerin,免疫比浊法检测血清hs-CRP,同时测定空腹血糖(FPG)、空腹胰岛素(FINS),并计算胰岛素抵抗指数(HOMA-IR)。结果与健康对照组相比较,NAFLD组患者的血清chemerin和hs-CRP水平明显升高(P<0.05)。与健康对照组和NAFLD组比较,NAFLD+IR组患者的血清chemerin和hs-CRP水平也明显升高(P<0.05)。血清chemerin水平与hs-CRP、HOMA-IR呈显著正相关。结论 NAFLD患者的血清chemerin水平与hs-CRP、HOMA-IR相关。 Objective To detect the serum levels of chemerin and high-sensitivity C-reactive protein(hs-CRP)in the patients with nonalcoholic fatty liver disease(NAFLD)and homeostasis model assessment of insulin resistance(HOMA-IR),and to investigate the mechanism of chemerin in NAFLD.Methods The patients with NAFLD were divided into the NAFLD group(30cases)and the NAFLD+IR group(30cases);other 30 individuals undergoing the healthy physical examination were selected as the healthy control group.The serum levels of chemerin and hs-CRP were measured by ELISA and immunoturbidimetry,respectively.Meanwhile,the fasting plasma glucose(FPG)and fasting insulin(FINS)were detected,and HOMA-IR was calculated.Results The levels of serum chemerin and hs-CRP in the NAFLD group were increased obviously compared with the healthy control group(P〈0.05).The levels of serum chemerin and hs-CRP in the NAFLD+IR group were significantly increased compared with the NAFLD group and healthy control group(P〈0.05).The serum chemerin level was positively correlated with the hs-CRP level and HOMAIR.Conclusion The serum chemerin level is correlated with hs-CRP and HOMA-IR in NAFLD patients.
出处 《重庆医学》 CAS 北大核心 2017年第2期172-174,共3页 Chongqing medicine
基金 广西教育厅科研基金资助项目(2013LX075 2013LX077) 广西卫生厅科研基金资助项目(Z2013489) 广西桂林市卫生局科学研究与技术开发计划资助项目(20120121-1-14)
关键词 C反应蛋白质 脂肪类 肝疾病 非酒精性脂肪肝病 胰岛素抵抗 视黄酸受体反应蛋白2 超敏C反应蛋白 C-reactive protein fats liver diseases nonalcoholic fatty liver disease insulin resistance chemerin high-sensitive C-reactive protein
  • 相关文献

参考文献2

二级参考文献28

  • 1赵维纲,朱惠娟.肥胖致胰岛素抵抗和高血糖的机制、治疗及评测[J].中国医学科学院学报,2010,32(1):7-12. 被引量:24
  • 2焦谊,常曦,王丽凤,李俊红,关亚群.重组chemerin蛋白对3T3-L1脂肪细胞visfatin、MCP-1基因表达的影响[J].中国老年学杂志,2014,34(2):414-417. 被引量:1
  • 3胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 4Lok AS,McMahon BJ; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.
  • 5Farrell GC,George J,Pauline de la M.Hall and McCullough A J,eds.Fatty liver disease:NASH and related disorders.Oxford:Blackwell Publishing,2005,1-22.
  • 6American Gastroenterological Association.American Gastroenterological Association Medical Position Statement:nonalcoholic fatty liver disease.Gastroenterology,2002,123:1702-1704.
  • 7Sanyal AJ.AGA technical review on nonalcoholic fatty liver disease.Gastroenterology,2002,123:1705-1725.
  • 8Ramesh S,Sanyal AJ.Evaluation and management of non-alcoholic steatohepatitis.J Hepatol,2005,42:S2-S12.
  • 9Eckel RH,Grundy SM,Zimmet PZ.The metabolic syndrome.Lancet,2005,365:1415-1428.
  • 10Graif M,Yanuka M,Baraz M,et al.Quantitative estimation of attenuation in ultrasound video images:correlation with histology in diffuse liver disease.Invest Radiol,2000,35:319-324.

共引文献211

同被引文献75

引证文献10

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部